Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2018

Open Access 01-12-2018 | Research article

Analysis of influencing factor of coexisting prediabetes and prehypertension in adult residents of Jilin Province

Authors: Xiaowei Wang, Mingjie Wang, Shuangshuang Shao, Yang Zhang, Siyu Liu, Yue Gao, Yuhang Shen, Pinghui Sun

Published in: BMC Endocrine Disorders | Issue 1/2018

Login to get access

Abstract

Background

To explore the risk factors of coexisting prediabetes and prehypertension, to provide theoretical basis for early intervention.

Methods

A multi-stage stratified random cluster sampling method was used to randomly select adult residents from Jilin Province in 2013 for questionnaire surveys, physical examinations, and laboratory tests.

Results

The prevalence of coexisting prediabetes and prehypertension in Jilin Province was 11.3%. The binary Logistic regression results showed that age, sex, education, triglyceride (TG), BMI, waist circumference and alcohol consumption were the effects of factor coexisting prediabetes and prehypertension.

Conclusion

It is important to pay attention to the early stage of hypertension and diabetes, control the transition from prehypertension and prediabetes to hypertension and diabetes, and improve the health of residents.
Literature
1.
Zonghui F, Donghong L, Xuemei K, et al. Blood pressure outcome and its influencing factors in prehypertension patients. Health Vocat Educ. 2012;30(24):106–8.
2.
Jiayi S, Dong Z, Wang W, et al. Changes in blood pressure levels of 2740 people in Beijing in the past 10 years (1992-2002). Chinese J Hypertens. 2005;02:61–5.
3.
De Marco M, de Simone G, Roman MJ, et al. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the strong head study. Hypertension. 2009;54(5):974–80.CrossRef
4.
Chuanzhi Z, Ye Z, Wu Y. Effects of blood lipid levels on the outcome of pre-diabetes population. Modern Instrum Med. 2017;23(04):75–7.
5.
Zikai L, Deng H. Research progress on the relationship between diabetes and pre-diabetes and liver function transaminase. Guizhou Med. 2014;38(03):278–80.
6.
Jiang Dongdong, Han Tingting, Hu Yaomin. Meta-analysis of the annual conversion rate of various subtypes of glucose regulation to diabetes progression. J Shanghai Jiaotong Univ (Medical Sciences). 2014;34(06):815–819+ 835.
7.
Shibing T, Yan R, Xingwu Y, et al. Epidemiological investigation of diabetes and pre-diabetes in Chengdu in 2007. Chin J Diabetes. 2009;17(07):484–8.
8.
Ying L, Xiaomu L, Gao X. Research progress of abnormal glucose metabolism in hypertension. Chin J Clin Med. 2012;19(02):180–2.
9.
Hui L, Binyou W, Ya L, et al. Study on the relationship between prehypertension and glucose and lipid metabolism in community residents of Chengdu area. J Lingnan Cardiol. 2011;17(S1):173.
10.
The Expert Committee on the Diagnosis and the Classification of the Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97.CrossRef
11.
Bouraima Yasmine A.B. (Yan Siimi). Investigation on the status of abnormal glucose metabolism in the elderly with hypertension in Tianjin urban area. Tianjin Medical University; 2013.
12.
Jie Wu, Wenhua Yan, Ling Qiu, et al. High prevalence of coexisting prehypertension and prediabetes among Healthy adults in northern and northeastern China. BMC Public Health. 2011;11(1):794.
13.
Luo X, Lu Z, Biying H, et al. Prevalence and influencing factors of pre-hypertension in pre-hypertension in middle-aged and elderly people in Chengdu area. China Circ Mag. 2015;30(10):984–8.
14.
Wenhua Z, Guang N, National Project Working Group of China Chronic Disease Monitoring (2010) Project. Contents and methods of China’s chronic disease surveillance project in 2010. Chin J Prev Med. 2012;46(5):477–9.
15.
Zhu J, Gao R, Liang Z, et al. Guidelines for prevention and treatment of dyslipidemia in Chinese adults (2016 revised edition). Chin J Circ. 2016;31(10):937–53.
16.
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org 1999. (World Health Organization. Diabetes and its Definition, diagnosis and classification of complications: WHO consultation report. Part 1: Diagnosis and classification of diabetes. Geneva, World Health Organization 1999.)
17.
Lisheng L. Guidelines for prevention and treatment of hypertension in China 2010. Chin J Hypertens. 2011;19(08):701–43.
18.
Qingmin L, Wenxiu C, Jinru L, Jun L. Unconditional logistic regression analysis of influential factors of abnormal blood pressure. Chinese J Prev Med. 2009;10(06):462–5.
19.
Hui Z, Xia C, Wang Y, et al. Epidemiological investigation and risk factors analysis of prehypertension in community in Changsha City. J Cent South Univ (Medical Sciences). 2016;41(07):750–6.
20.
Fusong J, Xuhong H, Yang L, et al. Prevalence of diabetes mellitus and its related factors in Jinuo adults in Yunnan Province. S Dis Monit. 2016;31(07):598–602.
21.
Chen Ruifang, Chang Shaoqiong. Analysis of risk factors in prediabetes and the application of Ba Duanjin. 2013,28(12):2531–2533.
22.
Gao Z. Diagnostic criteria and changes of diabetes and impaired glucose regulation. Int J Endocrinol Metab. 2006;02:141–4.
Metadata
Title
Analysis of influencing factor of coexisting prediabetes and prehypertension in adult residents of Jilin Province
Authors
Xiaowei Wang
Mingjie Wang
Shuangshuang Shao
Yang Zhang
Siyu Liu
Yue Gao
Yuhang Shen
Pinghui Sun
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2018
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-018-0316-5

Other articles of this Issue 1/2018

BMC Endocrine Disorders 1/2018 Go to the issue

Case report

Case Report: Identification of an HNF1B p.Arg527Gln mutation in a Maltese patient with atypical early onset diabetes and diabetic nephropathy

Case report

Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review

Research article

Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4)

Research article

ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome

Research article

Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan

Case report

Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman – a case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits